University of Texas MD Anderson Cancer Center

Hospital


Location: Houston, United States (USA) (US) US

ISNI: 0000000122914776

ROR: https://ror.org/04twxam07

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025) Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching P, Bardia A, Chia S, et al. Journal article The Value of Circulating Tumor HPV DNA in Head and Neck Squamous Cell Cancer: A Review † (2025) Dok R, Nuyts S, Lopez F, Bradford C, Forastiere AA, Strojan P, Agaimy A, et al. Journal article, Review article Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report (2025) Van den Bent MJ, Vogelbaum MA, Cloughesy T, Galldiks N, Albert NL, Tonn JC, Avila E, et al. Journal article, Review article Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer (2025) Al-Hilal TA, Chrysovergi MA, Grasberger PE, Liu F, Auernheimer V, Zhou Y, Xiao Z, et al. Journal article Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis (2025) Fu Z, Borho L, Taylor SE, Kelemen LE, DeFazio A, Webb PM, Köbel M, et al. Journal article Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial (2025) Fasching P, Slamon D, Nowecki Z, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, Huang CS, et al. Journal article Change of the guards—Looking back at Michael Droller: Visionary and supporter—The perspective of the International Bladder Cancer Network (2025) Schmitz-Dräger B, Grossmann HB, Goebell P, Kamat AM, Black PC Journal article A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial (2025) Hortobagyi GN, Lacko A, Sohn J, Cruz F, Ruiz Borrego M, Manikhas A, Hee Park Y, et al. Journal article Joint ABS/GEC-ESTRO Consensus Statement on the objectives of training in brachytherapy for physicians (2025) Keyes M, Sturdza AE, Crook J, Anderson B, Boldrini L, Chino J, Corradini S, et al. Journal article Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey. (2025) Hauschild A, Garbe C, Ascierto PA, Demidov L, Dreno B, Dummer R, Eggermont A, et al. Journal article